Baolai Hua

495 total citations
40 papers, 288 citations indexed

About

Baolai Hua is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Baolai Hua has authored 40 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 13 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Baolai Hua's work include Hemophilia Treatment and Research (21 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Platelet Disorders and Treatments (10 papers). Baolai Hua is often cited by papers focused on Hemophilia Treatment and Research (21 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Platelet Disorders and Treatments (10 papers). Baolai Hua collaborates with scholars based in China, United States and Canada. Baolai Hua's co-authors include Junjiang Sun, Yongqiang Zhao, Tienan Zhu, Yongqiang Zhao, Paul E. Monahan, Maureane Hoffman, Ted A. Bateman, Dougald M. Monroe, M.A. Karsdal and Adrienne Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Baolai Hua

38 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baolai Hua China 11 191 88 81 27 22 40 288
Verónica Palma‐Barqueros Spain 10 212 1.1× 53 0.6× 42 0.5× 56 2.1× 40 1.8× 15 288
Huong Nguyen United States 6 150 0.8× 154 1.8× 78 1.0× 26 1.0× 8 0.4× 16 294
Isabelle A. van Zeventer Netherlands 8 211 1.1× 166 1.9× 42 0.5× 20 0.7× 13 0.6× 16 279
Ihosvany Fernández Bello Spain 13 300 1.6× 49 0.6× 49 0.6× 11 0.4× 80 3.6× 36 391
Shaoqing Wu China 10 43 0.2× 45 0.5× 85 1.0× 36 1.3× 34 1.5× 30 255
Chad P. Soupir United States 8 182 1.0× 92 1.0× 64 0.8× 14 0.5× 11 0.5× 9 304
Rocco Pastano Italy 10 177 0.9× 74 0.8× 80 1.0× 19 0.7× 15 0.7× 19 285
Yasufumi Kawasaki Japan 9 93 0.5× 36 0.4× 34 0.4× 12 0.4× 19 0.9× 19 173
Shadan Lalezari Israel 13 344 1.8× 82 0.9× 81 1.0× 19 0.7× 8 0.4× 38 445
Francesca Vendemini Italy 10 121 0.6× 34 0.4× 136 1.7× 24 0.9× 16 0.7× 16 302

Countries citing papers authored by Baolai Hua

Since Specialization
Citations

This map shows the geographic impact of Baolai Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baolai Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baolai Hua more than expected).

Fields of papers citing papers by Baolai Hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baolai Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baolai Hua. The network helps show where Baolai Hua may publish in the future.

Co-authorship network of co-authors of Baolai Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Baolai Hua. A scholar is included among the top collaborators of Baolai Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baolai Hua. Baolai Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Baolai, et al.. (2024). Anti-inflammatory effect of a novel piperazino-enaminone delivered by liposomes in a mouse model of hemophilic arthropathy. International Journal of Pharmaceutics. 659. 124291–124291. 1 indexed citations
2.
Yu, Yang, Hao Wang, Jingjing Yang, et al.. (2023). A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia. Frontiers in Oncology. 13. 1144403–1144403.
3.
Li, Min, et al.. (2020). Exploring the Potential Feasibility of Intra-Articular Adeno-Associated Virus-Mediated Gene Therapy for Hemophilia Arthropathy. Human Gene Therapy. 31(7-8). 448–458. 6 indexed citations
4.
Sun, Junjiang, et al.. (2019). Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model. Inflammation. 42(5). 1719–1729. 2 indexed citations
5.
He, Ping, et al.. (2019). Timely and large dose of clotting factor IX provides better joint wound healing after hemarthrosis in hemophilia B mice. International Journal of Hematology. 110(1). 59–68. 3 indexed citations
6.
Xu, Mengyang, Qin Yang, Baolai Hua, et al.. (2019). A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy. Journal of Clinical Medicine. 9(1). 75–75. 7 indexed citations
7.
Hua, Baolai, et al.. (2018). The endothelial specific isoform of type XVIII collagen correlates to annual bleeding rate in haemophilia patients. PLoS ONE. 13(1). e0190375–e0190375. 8 indexed citations
8.
Hua, Baolai, Runhui Wu, Feifei Sun, et al.. (2017). Confirmation of longer FIX activity half-life with prolonged sample collection after single doses of nonacog alfa in patients with haemophilia B. Thrombosis and Haemostasis. 117(6). 1052–1057. 10 indexed citations
10.
Sun, Junjiang, Baolai Hua, Xiaojing Chen, R. Jude Samulski, & Chengwen Li. (2017). Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies. Human Gene Therapy. 28(8). 654–666. 15 indexed citations
11.
Yang, Hang, Baolai Hua, Tienan Zhu, et al.. (2016). Reversible MRI findings in a case of acute intermittent porphyria with a novel mutation in the porphobilinogen deaminase gene. Blood Cells Molecules and Diseases. 63. 21–24. 8 indexed citations
12.
14.
Zhu, Tienan, et al.. (2015). Normal range and genetic analysis of coagulation factor XII in the general Chinese population. Thrombosis Research. 136(2). 440–444. 6 indexed citations
15.
Qi, Xue, et al.. (2014). Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors. Blood Coagulation & Fibrinolysis. 25(7). 754–760. 16 indexed citations
16.
Hua, Baolai, et al.. (2010). A Novel Mutation (G2172→C) in the Factor V Gene in a Chinese Family with Hereditary Activated Protein C Resistance. Thrombosis Research. 125(6). 545–548. 13 indexed citations
17.
Hua, Baolai, et al.. (2009).  1-antitrypsin Pittsburgh in a family with bleeding tendency. Haematologica. 94(6). 881–884. 15 indexed citations
18.
Yan, Zhenyu, Baolai Hua, Shujie Wang, et al.. (2007). [Risk factors analysis in 672 hospitalized patients with venous thromboembolism].. PubMed. 28(9). 579–82. 1 indexed citations
19.
Zhu, Yi‐Cheng, Liying Cui, Baolai Hua, & J. Pan. (2006). Correlation between fibrinogen level and cerebral infarction.. PubMed. 21(3). 167–70. 2 indexed citations
20.
Hua, Baolai, et al.. (2005). Multiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpura. Blood Coagulation & Fibrinolysis. 16(4). 291–295. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026